yet nearly all have a shortage of medical physicists, radiation therapy technologists, and engineers to maintain equipment.

Ivermectin is an antiparasitic agent, and its potential as an anticancer agent has recently attracted increasing attention.

Despite a 21.8% revenue increase, The Oncology Institute Inc (TOI) faces ongoing financial hurdles and NASDAQ compliance issues.

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

Good afternoon and welcome to The Oncology Institute's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this ...

Credit: NASA Wednesday’s research aboard the International Space Station (ISS) focused on DNA-like nanomaterials, ultrasound ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...

Cryoport, Inc. ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced the opening of its newest IntegriCelltm facility in ...

Through partnership with Legion Healthcare Partners, proton therapy system will target tumors without "exit radiation" ...